Cargando…

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease

The SARS-CoV-2 pandemic caused a massive health and societal crisis, although the fast development of effective vaccines reduced some of the impact. To prepare for future respiratory virus pandemics, a pan-viral prophylaxis could be used to control the initial virus outbreak in the period prior to v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmermann, Julie, Schmidt, Signe Tandrup, Trebbien, Ramona, Cox, Rebecca Jane, Zhou, Fan, Follmann, Frank, Pedersen, Gabriel Kristian, Christensen, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836410/ https://www.ncbi.nlm.nih.gov/pubmed/35163772 http://dx.doi.org/10.3390/ijms23031850

Ejemplares similares

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
por: Schmidt, Signe Tandrup, et al.
Publicado: (2020)

Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction
por: Wørzner, Katharina, et al.
Publicado: (2021)

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile
por: Schmidt, Signe Tandrup, et al.
Publicado: (2016)

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
por: Tandrup Schmidt, Signe, et al.
Publicado: (2016)

Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
por: Agger, Else Marie, et al.
Publicado: (2008)

Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
por: Sisteré-Oró, Marta, et al.
Publicado: (2020)

Robust antibody and CD8(+) T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection
por: Espinosa, Diego A., et al.
Publicado: (2017)

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014
por: Trebbien, Ramona, et al.
Publicado: (2017)

Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C)
por: Schmidt, Signe Tandrup, et al.
Publicado: (2018)

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma
por: Mørk, Sofie Kirial, et al.
Publicado: (2022)

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice
por: Wørzner, Katharina, et al.
Publicado: (2021)

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
por: Christensen, Dennis, et al.
Publicado: (2018)

The Impact of Solvent Selection: Strategies to Guide the Manufacturing of Liposomes Using Microfluidics
por: Webb, Cameron, et al.
Publicado: (2019)

CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
por: Martel, Cyril Jean-Marie, et al.
Publicado: (2011)

First in man study: Bcl-Xl_42-CAF(®)09b vaccines in patients with locally advanced prostate cancer
por: Mørk, Sofie Kirial, et al.
Publicado: (2023)

CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
por: van Haren, Simon D., et al.
Publicado: (2022)

Reassortant Influenza A(H1N1)pdm09 Virus in Elderly Woman, Denmark, January 2021
por: Nissen, Jakob N., et al.
Publicado: (2021)

Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves
por: Thakur, Aneesh, et al.
Publicado: (2018)

Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract
por: Wern, Jeanette Erbo, et al.
Publicado: (2017)

Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis
por: Christensen, Dennis, et al.
Publicado: (2010)

MF59(®)‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
por: Banzhoff, Angelika, et al.
Publicado: (2008)

Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes
por: Ciabattini, Annalisa, et al.
Publicado: (2015)

Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
por: Dietrich, Jes, et al.
Publicado: (2014)

Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF(®)01 or CDA/αGalCerMPEG
por: López-Serrano, Sergi, et al.
Publicado: (2021)

A case of reassortant seasonal influenza A(H1N2) virus, Denmark, April 2019
por: Trebbien, Ramona, et al.
Publicado: (2019)

Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses
por: Pedersen, Gabriel Kristian, et al.
Publicado: (2020)

Immune responses following neonatal vaccination with conserved F4 fragment of VtaA proteins from virulent Glaesserella parasuis adjuvanted with CAF®01 or CDA
por: López-Serrano, Sergi, et al.
Publicado: (2023)

Co-circulation of multiple influenza A reassortants in swine harboring genes from seasonal human and swine influenza viruses
por: Ryt-Hansen, Pia, et al.
Publicado: (2021)

Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
por: Hovden, Arnt-Ove, et al.
Publicado: (2007)

Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs
por: Trebbien, Ramona, et al.
Publicado: (2011)

A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8(+) Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice
por: Gram, Gregers Jacob, et al.
Publicado: (2009)

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
por: Li, Zhaohuan, et al.
Publicado: (2021)

Response to influenza vaccination in immunocompromised children with rheumatic disease: a prospective cohort study
por: Jensen, Lotte, et al.
Publicado: (2021)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Influenza A Virus with a Human-Like N2 Gene Is Circulating in Pigs
por: Breum, Solvej Østergaard, et al.
Publicado: (2013)

Injection Vaccines Formulated with Nucleotide, Liposomal or Mineral Oil Adjuvants Induce Distinct Differences in Immunogenicity in Rainbow Trout
por: Rømer Villumsen, Kasper, et al.
Publicado: (2020)

iMovie 09 and iDVD 09 for dummies
por: Cohen, Dennis R, et al.
Publicado: (2009)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Liposomes as Adjuvants and Vaccine Delivery Systems
por: Tretiakova, D. S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sulan61btt9dkq0eu9pm2nvdet